| Zachary John Yoder, PA-C | |
|
371 Lafayette St, London, OH 43140-9326 | |
| (740) 845-6735 | |
| Not Available |
| Full Name | Zachary John Yoder |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 371 Lafayette St, London, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609639194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50.008626RX (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Zachary John Yoder, PA-C 371 Lafayette St, London, OH 43140-9326 Ph: (614) 381-8280 | Zachary John Yoder, PA-C 371 Lafayette St, London, OH 43140-9326 Ph: (740) 845-6735 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that it has signed a 10-year supply agreement with MSD Biologics (UK) Ltd, part of the Merck BioManufacturing Network, for the production of microplasmin. ThromboGenics anticipates that this deal will meet its long-term commercial needs for bulk drug substance of this novel therapeutic agent.
St George's, University of London and Moorfields Eye Hospital NHS Foundation Trust are leading a half a million pound project on artificial intelligence (AI), funded by NHSX and the Health Foundation, and enabled by the National Institute for Health Research.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced that on July 26, 2010 it received a letter from the NYSE Amex LLC, stating that PharmAthene is not in compliance with the continued listing standards specified in Sections 1003(a)(i), (ii) and (iii) of the NYSE Amex Company Guide, because it has stockholders' equity of less than $2.0 million, $4.0 million and $6.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years, three of its four most recent fiscal years and its five most recent fiscal years, respectively.
Heart disease patients 65 and older who receive stents coated with medicine to prevent blockages are more likely to survive and less likely to suffer a heart attack than people fitted with stents not coated with medication, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry.
The Wall Street Journal Health Blog: "The United States Preventive Services Task Force has canceled a meeting set for early next month at which the thorny issue of prostate-cancer screening was due for a vote. ... [W]hen prostate-cancer screening came up last fall, the USPSTF initially voted to recommend against screening for men of all ages before opting instead to re-vote on the issue.
› Verified 9 days ago
Rachel Fraser, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 210 N Main St, London, OH 43140 Phone: 614-499-1561 | |
Mrs. Krystal Nicole Foley, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 210 N Main St, London, OH 43140 Phone: 740-845-7333 | |
Leah Danielle Triplet, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 210 N Main St, London, OH 43140 Phone: 716-359-0007 | |
Sara S Lyons, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 210 N Main St, London, OH 43140 Phone: 740-845-7000 Fax: 740-845-7701 |